A study led by Jenner Investigator Prof Simon Draper has identified the antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood. The researchers from the Jenner Institute along with partners from five institutions around the world, have identified the human antibodies that prevent the malaria parasite from entering blood cells, which may be key to creating a highly effective malaria vaccination. The results of the study were published today in the journal Cell.
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1. Mol Ther Methods Clin Dev, 14, pp. 148-160. Article
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technol Assess, 23 (38), pp. 1-92. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Dr Tom Evans: Mathematical modelling of dose responses in vaccine studies, 19/Sep/2019 11:00